The incidence of serious adverse reactions was 8%, compared to 7% with the placebo
no video visit unless clinically necessary Initial review typically completed within 2448 hours after intake Treatments Offered Weekly GLP-1 injections: Ozempic, Wegovy, Mounjaro, Zepbound, compounded semaglutide, and compounded liraglutide Daily (once or twice) oral weight-loss medications: bupropion, metformin, topiramate, B12, naltrexone App-based sleep, nutrition, and exercise guidance: included Additional services : birth control, ED treatment, skincare, mental health Bottom Line Hims and Hers is a solid option for adults who want GLP-1 access through a trusted, gender-specific telehealth brand
Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients
The record needs to explicitly confirm that the patient is currently on a prescribed, ongoing insulin regimen
doi: 10.2337/dc15-0488 17 CaniP
J.GrossJ